← Back
$DNLI All transactions

Denali Therapeutics Inc.

A

$ Value

$0

Shares

236,880

Price

$0

Filed

Jan 5

Insider

Name

Watts Ryan J.

Title

President and CEO

CIK

0001724310

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

236,880

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2027 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date. | Includes 184,915 Unvested RSUs. | The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. | 25% of the shares subject to the option shall vest on January 3, 2027, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date

Filing Info

Accession No.

0001724310-26-000001

Form Type

4

Issuer CIK

0001714899

Watts Ryan J.'s History

Date Ticker Type Value
2026-01-06 DNLI $581K
2026-01-03 DNLI A $0
2026-01-03 DNLI A $0
2025-09-03 DNLI G $0
2025-07-09 DNLI M $310K
2025-07-09 DNLI M $211K
2025-07-09 DNLI $7.4M
2025-07-09 DNLI M $0
2025-07-09 DNLI M $0

Other Insiders at DNLI (90d)

No other insider activity at this issuer in the last 90 days.